JP2022500382A5 - - Google Patents
Info
- Publication number
- JP2022500382A5 JP2022500382A5 JP2021513309A JP2021513309A JP2022500382A5 JP 2022500382 A5 JP2022500382 A5 JP 2022500382A5 JP 2021513309 A JP2021513309 A JP 2021513309A JP 2021513309 A JP2021513309 A JP 2021513309A JP 2022500382 A5 JP2022500382 A5 JP 2022500382A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- residues
- antibody
- sle
- use according
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862729354P | 2018-09-10 | 2018-09-10 | |
| US62/729,354 | 2018-09-10 | ||
| PCT/US2019/050262 WO2020055768A1 (en) | 2018-09-10 | 2019-09-09 | Methods for treating pancreatitis |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022500382A JP2022500382A (ja) | 2022-01-04 |
| JPWO2020055768A5 JPWO2020055768A5 (https=) | 2022-09-20 |
| JP2022500382A5 true JP2022500382A5 (https=) | 2022-09-20 |
| JP7560445B2 JP7560445B2 (ja) | 2024-10-02 |
Family
ID=69776851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021513309A Active JP7560445B2 (ja) | 2018-09-10 | 2019-09-09 | 膵炎を処置するための方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12378320B2 (https=) |
| EP (1) | EP3849605A4 (https=) |
| JP (1) | JP7560445B2 (https=) |
| KR (1) | KR20210073515A (https=) |
| CN (2) | CN120267815A (https=) |
| AU (1) | AU2019337564A1 (https=) |
| BR (1) | BR112021004444A2 (https=) |
| CA (1) | CA3112382A1 (https=) |
| CL (2) | CL2021000585A1 (https=) |
| IL (1) | IL281343A (https=) |
| MX (1) | MX2021002761A (https=) |
| SG (1) | SG11202102416SA (https=) |
| WO (1) | WO2020055768A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202102416SA (en) | 2018-09-10 | 2021-04-29 | Cold Spring Harbor Laboratory | Methods for treating pancreatitis |
| US20250297027A1 (en) * | 2021-01-12 | 2025-09-25 | Yeda Research And Development Co. Ltd. | Antibodies to cancer glycosylation and uses thereof |
| JP2024511189A (ja) * | 2021-03-26 | 2024-03-12 | ビオンテック・ソシエタス・エウロパエア | がんの処置における抗ｃａ１９－９抗体およびｆｏｌｆｉｒｉｎｏｘを用いた組合せ療法。 |
| US20250302409A1 (en) * | 2024-03-26 | 2025-10-02 | Hepatiq, Inc. | Determining pancreas disease using functional imaging |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018653A (en) | 1971-10-29 | 1977-04-19 | U.S. Packaging Corporation | Instrument for the detection of Neisseria gonorrhoeae without culture |
| US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
| US4471057A (en) | 1981-06-30 | 1984-09-11 | The Wistar Institute | Detection of colorectal carcinoma |
| US4424279A (en) | 1982-08-12 | 1984-01-03 | Quidel | Rapid plunger immunoassay method and apparatus |
| US5051448A (en) | 1984-07-24 | 1991-09-24 | The Mclean Hospital Corporation | GABA esters and GABA analog esters |
| US4704355A (en) | 1985-03-27 | 1987-11-03 | New Horizons Diagnostics Corporation | Assay utilizing ATP encapsulated within liposome particles |
| JPS63159763A (ja) * | 1986-12-24 | 1988-07-02 | Fujirebio Inc | 逆受身凝集反応試薬 |
| CA2025907A1 (en) | 1989-09-21 | 1991-03-22 | Franklin D. Collins | Method of transporting compositions across the blood brain barrier |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| US5559103A (en) | 1993-07-21 | 1996-09-24 | Cytel Corporation | Bivalent sialyl X saccharides |
| US5576423A (en) | 1994-12-02 | 1996-11-19 | Schering Corporation | Antibodies to the slam protein expressed on activated T cells |
| US7238715B2 (en) | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
| HUE026444T2 (en) | 2005-08-05 | 2016-05-30 | Araim Pharmaceuticals Inc | Tissue protection peptides and their use |
| FI20070853A0 (fi) * | 2007-11-09 | 2007-11-09 | Glykos Finland Oy | Glykaania sitovat monoklonaaliset vasta-aineet |
| WO2009094172A2 (en) | 2008-01-22 | 2009-07-30 | Araim Pharmaceuticals, Inc. | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
| JP5919604B2 (ja) | 2008-08-08 | 2016-05-18 | イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． | 抗膵癌抗体 |
| EP3385277A1 (en) | 2013-03-15 | 2018-10-10 | F. Hoffmann-La Roche AG | Il-22 polypeptides and il-22 fc fusion proteins and methods of use |
| HK1223298A1 (zh) | 2013-07-17 | 2017-07-28 | 阿拉伊姆药品公司 | 预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物 |
| KR102313341B1 (ko) * | 2013-08-26 | 2021-10-18 | 바이오엔테크 리서치 앤드 디벨롭먼트 인코포레이티드 | 시알릴-루이스 ａ에 대한 사람 항체 코드화 핵산 |
| CN104623639A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | 白介素22二聚体在制备治疗胰腺炎药物中的应用 |
| PT3097122T (pt) | 2014-01-24 | 2020-07-21 | Ngm Biopharmaceuticals Inc | Anticorpos de ligação de domínio 2 de beta klotho e métodos de utilização dos mesmos |
| WO2017019957A2 (en) | 2015-07-29 | 2017-02-02 | Ngm Biopharmaceuticals, Inc. | Binding proteins and methods of use thereof |
| EP3448874A4 (en) * | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| SG11202102416SA (en) | 2018-09-10 | 2021-04-29 | Cold Spring Harbor Laboratory | Methods for treating pancreatitis |
-
2019
- 2019-09-09 SG SG11202102416SA patent/SG11202102416SA/en unknown
- 2019-09-09 BR BR112021004444-2A patent/BR112021004444A2/pt unknown
- 2019-09-09 CA CA3112382A patent/CA3112382A1/en active Pending
- 2019-09-09 KR KR1020217008242A patent/KR20210073515A/ko not_active Ceased
- 2019-09-09 AU AU2019337564A patent/AU2019337564A1/en active Pending
- 2019-09-09 JP JP2021513309A patent/JP7560445B2/ja active Active
- 2019-09-09 CN CN202510438979.9A patent/CN120267815A/zh active Pending
- 2019-09-09 EP EP19859491.3A patent/EP3849605A4/en active Pending
- 2019-09-09 US US17/274,783 patent/US12378320B2/en active Active
- 2019-09-09 CN CN201980073543.7A patent/CN113056286B/zh active Active
- 2019-09-09 WO PCT/US2019/050262 patent/WO2020055768A1/en not_active Ceased
- 2019-09-09 MX MX2021002761A patent/MX2021002761A/es unknown
-
2021
- 2021-03-09 CL CL2021000585A patent/CL2021000585A1/es unknown
- 2021-03-09 IL IL281343A patent/IL281343A/en unknown
-
2022
- 2022-01-13 CL CL2022000091A patent/CL2022000091A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024150751A5 (https=) | ||
| KR102757960B1 (ko) | 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료 | |
| AU2025203751A9 (en) | Anti-BCMA heavy chain-only antibodies | |
| JP2022500382A5 (https=) | ||
| CA3146341A1 (en) | Bispecific anti lrrc15 and cd3epsilun antibudies | |
| CN103172742A (zh) | 人cd22特异性抗体及其治疗和诊断应用 | |
| JP2012515746A (ja) | 抗ｃｄ１６０モノクローナル抗体及びその使用 | |
| JP2010504755A5 (https=) | ||
| WO2014198748A1 (en) | Anti-her2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer | |
| KR20230008775A (ko) | Cd3 및 cd20에 대한 이중특이적 항체 | |
| TWI855014B (zh) | Muc18特異性抗體 | |
| US20210355229A1 (en) | An anti-ox40 antibody, antigen-binding fragment thereof, and the pharmaceutical use | |
| JP2023542291A (ja) | びまん性大細胞型ｂ細胞リンパ腫を治療するための併用療法におけるｃｄ３及びｃｄ２０に対する二重特異性抗体 | |
| US20240092875A1 (en) | Sars-cov-2 antibodies for treatment and prevention of covid-19 | |
| JP2020527152A5 (https=) | ||
| US20250129176A1 (en) | Cd19/cd38 multispecific antibodies | |
| RU2019140933A (ru) | Средства, пути применения и способы лечения | |
| JP2024540395A (ja) | Ｃｏｖｉｄ－１９を治療及び予防するための組成物 | |
| CN112480259B (zh) | 抗tnfr2抗体及其用途 | |
| CN115957321A (zh) | 一种抗her2抗体在制备治疗癌症的药物中的用途 | |
| TW202321303A (zh) | 抗pla2r自體抗體媒介膜性腎病變之治療 | |
| CA3227172A1 (en) | Methods for treating acute myeloid leukemia with anti-ilt3 antibodies | |
| JPWO2020055768A5 (https=) | ||
| KR20240072932A (ko) | B7-h3에 특이적으로 결합하는 항체 | |
| IL319999A (en) | Bispecific antibodies against CD3 and CD20 - for the treatment of Richter syndrome |